Von Willebrand Diseases clinical trials at UC Health
2 in progress, 1 open to new patients
open to eligible people ages 21 years and up
This study will measure primary hemostatic ability using the T-TAS 01 System with PL chip, with a comparison to clinical truth.
Sorry, not yet accepting patients
ATHN 9 is a natural history study to assess the safety of various Von Willebrand Factor (VWF) regimens for different indications (on-demand, surgery and prophylaxis) in adult and pediatric participants with clinically severe congenital VWD.